Oppenheimer Weighs in on UnitedHealth Group Incorporated’s Q4 2017 Earnings (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) – Oppenheimer increased their Q4 2017 earnings estimates for UnitedHealth Group in a report issued on Tuesday. Oppenheimer analyst M. Wiederhorn now forecasts that the healthcare conglomerate will post earnings of $2.50 per share for the quarter, up from their previous estimate of $2.48. Oppenheimer currently has a “Outperform” rating and a $225.00 target price on the stock.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same period last year, the business earned $2.17 EPS. The company’s revenue was up 8.7% compared to the same quarter last year.

Other analysts have also recently issued reports about the stock. Wells Fargo & Company restated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday. Jefferies Group restated a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a report on Friday. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a report on Friday. Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Cowen reaffirmed an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Three investment analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $224.56.

UnitedHealth Group (NYSE UNH) traded up $5.29 during trading hours on Friday, hitting $228.17. 6,846,300 shares of the stock were exchanged, compared to its average volume of 3,107,045. UnitedHealth Group has a twelve month low of $155.18 and a twelve month high of $228.75. The company has a market cap of $209,588.95, a PE ratio of 22.53, a P/E/G ratio of 1.60 and a beta of 0.64. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.

Institutional investors and hedge funds have recently bought and sold shares of the business. Institutional & Family Asset Management LLC grew its stake in UnitedHealth Group by 4.6% in the 3rd quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock valued at $3,789,000 after acquiring an additional 857 shares during the period. Steward Partners Investment Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $7,787,000. Visionary Asset Management Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $309,000. Jana Partners LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $44,601,000. Finally, Public Employees Retirement System of Ohio grew its stake in UnitedHealth Group by 1.2% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 711,891 shares of the healthcare conglomerate’s stock valued at $139,424,000 after acquiring an additional 8,769 shares during the period. 86.20% of the stock is owned by institutional investors.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 63,206 shares of company stock valued at $12,683,669 over the last three months. 0.89% of the stock is currently owned by insiders.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

ILLEGAL ACTIVITY NOTICE: This piece was first published by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/01/oppenheimer-weighs-in-on-unitedhealth-group-incorporateds-q4-2017-earnings-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply